Salmonella Conjugates CVD 1000: Study of Responses to Vaccination With Trivalent Invasive Salmonella Disease Vaccine

Conditions

• Risk Reduction

Interventions

• BIOLOGICAL: Trivalent Invasive Salmonella Disease Vaccine (6.25 µg)
• BIOLOGICAL: Trivalent Invasive Salmonella Disease Vaccine (12 µg)
• BIOLOGICAL: Trivalent Invasive Salmonella Disease Vaccine (25 µg)
• BIOLOGICAL: Trivalent Invasive Salmonella Disease Vaccine (highest, well-tolerated dose among Cohorts A-C)
• OTHER: Placebo

Sponsor

University of Maryland, Baltimore